Yan Luo retweeted
Detection bias in open-label trials of anticancer drugs: a meta-epidemiological study
Original Research by @funada_satoshi, @yluo06, @YukiKataoka3 and colleagues
#OpenAccess
Link: bit.ly/3ZHW36J
Yan Luo retweeted
Our paper has been published. We evaluated the research trends of highly cited studies related to COVID-19 by conducting a bibliometric analysis. The total number of highly cited studies peaked at the end of 2021 and showed a downward trend until the end of 2022.
These findings suggest that as the #COVID19 pandemic evolved in the 3 years since its outbreak, there were important shifts in trends of the number and origin of high-profile COVID-19 studies. ja.ma/3P7jHod
Yan Luo retweeted
【京都府臨床心理士会自殺対策シンポジウム】
自死遺族支援に長年取り組んできた石倉紘子さんを招いて、これまでの歩みを伺います。
元スタッフとして私も対談します。座長は京都文教大学の濱野清志さん。
9／17（日）対面＋オンライン、どなたでもご参加いただけます。
申込：docs.google.com/forms/d/e/1F…
❤️Many thanks to EBMLive 2022 & @dnunan79
Catalogue of bias: novelty bias
#EBMLearning by @yluo06, @carlheneghan, @NavPersaud
Link: bit.ly/3MHmkM4
Preview:
Just published our study applying a 2-stage model based on individual participant data meta-analysis. We examined patient-specific treatment effects of adding biologics to conventional rheumatoid arthritis treatment.@KChalkou @funada_satoshi @Geointheworld @Toshi_FRKW
Meta-analysis: The benefit of adding biologics to conventional rheumatoid arthritis treatment is uncertain for specific patients, and the interactive application based on a 2-stage model may help with treatment selection in practice. ja.ma/3PB8D4w